n Cardiovascular Journal of South Africa - EUROPA : clinical benefits, clinical promise : drug trends in cardiology
|Article Title||EUROPA : clinical benefits, clinical promise : drug trends in cardiology|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of South Africa|
|Publication Date||May 2004|
Extracted from text ... 147 EUROPA: clinical benefits, clinical promise Should we consider the routine administration of ACE inhibitors such as perindopril in all people with coronary artery disease (CAD)? 'Yes', said Professor Willem Remme of the 'Sticares' Cardiovascular Research Institute, Rhoon, the Netherlands, as he concluded his presentation on the EUROPA (EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease) study to doctors around South Africa. The EUROPA1 study was designed to assess whether the long-term administration of perindopril, added to standard preventative therapy, would reduce cardiovascular events in a broad spectrum of patients with definite evidence of ..
Article metrics loading...